Details for 2017798045
Up to date per 01.04.2026
Actions
Details for 2017798045
Granted/Registered
European Patent
04.09.2019 A
31.01.2024 B1
26.10.2016
US
201662413387 P
26.10.2016
US
201662413283 P
31.10.2016
US
201662415452 P
C12N 5/0783 20100101AFI20180504BHEP
Owner
Iovance Biotherapeutics, Inc.825 Industrial Road Suite 400 San Carlos, CA 94070US
Representative
Authorized Recipients
Dipl.-Ing. Yorck Hernandezc/o HERNANDEZ IP, Ludwig-Ganghofer-Straße 4282031 GrünwaldDE
Inventor
FRANK, Ian8302 Old Town Drive Tampa FL 33647US
LOTZE, Michael, T.5134 Westminster Place Pittsburgh PA 15232US
Information about Fees